[1]
Recognizing and Treating Hypertension 2005 Clinical Practice ...
[126,5 KB]
From [www.unityhealth.com] Last viewed: 21.09.2006
Recognizing & Treating Hypertension : Clinical Practice Guideline for Adults - October 2005 - Page 1
Recognizing and Treating Hypertension
2005 Clinical Practice Guideline for Adults > 18 Years Old
A guideline is designed to assist clinicians by providing a framework for the evaluation and treatment of patients. This guideline outlines
the preferred approach for most patients. It is not intended to replace a clinician’s judgment or to establish a protocol for all patients. It
is understood that some patients will not fit the clinical condition contemplated by a guideline and that a guideline will rarely establish the
only appropriate approach to a problem.
The purpose of treating hypertension is to reduce the incidence of stroke, myocardial infarction, congestive heart failure and renal failure.
Unless contraindicated or there is a compelling indication to use another medication, low dose diuretic therapy ...
[2]
Hypertension Hypertension Hypertension Hypertension Hypertension ...
[813,8 KB]
From [www.lsuagcenter.com] Last viewed: 21.09.2006
Hypertension
Hypertension
Hypertension
Hypertension
Hypertension
Hypertension
Say
High blood pressure makes your heart work
harder than it should to pump blood. If this
pressure isn’t controlled, your heart enlarges and
your arteries become scarred, hardened and less
elastic. Your overworked heart and stiff arteries
may not be able to pump blood properly, leading
to congestive heart failure (backup of fluid into the
lungs). High blood pressure also can damage the
inner linings of arteries, which leads to a buildup of
fatty deposits and other substances called plaque.
This condition, called atherosclerosis, is a major
cause of heart attack and stroke. This damage to
arteries also may cause kidney disease, vision loss
and shrinkage of the brain, leading to memory loss
and damage to thinking processes.
Say ...
[3]
HYPERTENSION QUESTIONNAIRE
[80,1 KB]
From [www.citrushc.com] Last viewed: 21.09.2006
TESTIMONY OF
MR. JACK STIBBS
CHAIRMAN OF THE BOARD
PULMONARY HYPERTENSION ASSOCIATION
ON BEHALF OF THE
PULMONARY HYPERTENSION ASSOCIATION
801 ROEDER RD, SUITE 400
SILVER SPRING, MD 20910
(301) 565-3004
REGARDING
FISCAL YEAR 2007 APPROPRIATIONS FOR CDC, NIH AND HRSA
PRESENTED TO THE
HOUSE LABOR-HHS-EDUCATION APPROPRIATIONS SUBCOMMITTEE
MARCH 29, 2006
SUMMARY OF FY 2007 RECOMMENDATIONS:
• $250,000 within the Centers for Disease Control and Prevention for a pulmonary
hypertension awareness and education program.
• A 5% increase for the National Heart, Lung and Blood Institute and the establishment
of “Specialized Centers of Clinically Orientated Research” on Pulmonary Hypertension
at the Institute.
• $25 million for the Health Resources and Services Administration’s “Gift of Life”
Donation Initiative. ...
[4]
JNC 7 guidelines for classifying, managing hypertension How JNC 7 ...
[82,4 KB]
From [www.acponline.org] Last viewed: 21.09.2006
hypertension on the basis of the TROPHY
results. She initiates drug treatment when
blood pressure hits ...
[5]
Implementing Evidence Based Treatment of Hypertension Peter J ...
[91,3 KB]
From [www1.va.gov] Last viewed: 21.09.2006
Implementing Evidence Based Treatment of Hypertension
Peter J. Kaboli, MD, MS
CRIISP, Iowa City, IA
BACKGROUND / RATIONALE:
Hypertension is common and readily treatable, yet only less than 40% of patients are adequately
treated. Treatment recommendations come from the 2002 Antihypertensive and Lipid-Lowering
Treatment to Prevent Heart Attack Trial (ALLHAT), the 2003 7th Report of the Joint National
Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7), and
the 1999 VA/DOD Clinical Practice Guidelines for Hypertension . These reports definitely state that
thiazide diuretics should be used as first-line therapy for patients with uncomplicated hypertension
The long-term goal of the proposed research is to develop an innovative intervention to implement
these recommendations regarding the use of thiazides and improve the blood pressure control of VA
primary ...
[6]
British Hypertension Society
[463,1 KB]
From [www.hamptonmedical.com] Last viewed: 21.09.2006
23
rd
August 2006
Dear Colleague,
Re:
British Hypertension Society / Nurses Hypertension Association Annual Scientific Meetings
Churchill College, Cambridge, Monday 18
th
- Wednesday 20
th
September 2006
We should like to take this opportunity of reconfirming your registration for this year’s meeting of the British
Hypertension Society and the Nurses Hypertension Association in Cambridge.
If you now find that you cannot attend for any reason, we would be grateful if you could inform us as soon
as possible. In particular we should be grateful if you could let us know as soon as possible should your
plans change for attending the Conference Dinner on Tuesday evening.
Note: The overspill ensuite accommodation originally booked for Trinity Hall is no longer available and
delegates already allocated rooms in Trinity Hall will now be staying ...
[7]
Recommendation for Hypertension Screening for the HealthCare ...
[52,7 KB]
From [www.uchsc.edu] Last viewed: 21.09.2006
hypertension
Recommendation for Hypertension Screening
for the HealthCare Professional
Hypertension 1
Defined as systolic blood pressure (SBP) =140 mmHg, diastolic blood pressure (DBP) =90 mmHg, or patients taking antihypertensive medications
Goal blood pressure in patients is <140/90 mmHg
Goal blood pressure in patients with diabetes or chronic kidney disease is <130/80
chronic kidney disease is defined as a CLcr < 60 ml/min, the presence of albuminuria (> 300 mg/day or > 200 mg albumin/g creatinine spot ratio), or a serum creatinine of > 1.3 g/dL for women and > 1.5 g/dL for men
Individuals with normal blood pressure levels at 55 years of age have a 90% lifetime risk of developing hypertension
Risk Factors for Hypertension 1-3,5
Patients with pre- hypertension
Cigarette smoking
Obesity (BMI ...
[8]
BCRCP OBstetRiC GUiDeLiNe 11 HyPeRteNsiON iN PReGNaNCy
[1858,3 KB]
From [www.rcp.gov.bc.ca] Last viewed: 21.09.2006
P
&
T D
IGEST
A PEER-REVIEWED COMPENDIUM OF FORMULARY CONSIDERATIONS
• Prevalence
and economic
implications
• Summary
of JNC-7 guidelines
• Trials underlying
JNC-7 guidelines
• Implications
of uncontrolled
hypertension
• Drug-therapy review
• Recommendations
for combination therapy
• NCQA standards and
quality measurement
•
Adherence to therapy
•
Formulary status of
antihypertensive agents
Vol.28,No.8
August 2003
S U P P L E M E N T T O
H
YPERTENSION
Continuing education credit for physicians and pharmacists
is sponsored byThe Chatham Institute
This program is supported by an unrestricted educational grant
from AstraZeneca
Pharmacy and Therapeutics
A Peer-Reviewed Journal for Managed Care
and Hospital Formulary ...
[9]
Hypertension
[98,2 KB]
From [www.aabt.org] Last viewed: 21.09.2006
Coping with Hypertension
Hypertension
Hypertension , or high blood pressure, is a very
common condition. Blood pressure is measured in
millimeters of mercury (mm Hg). The systolic pres-
sure (upper number) represents the pressure when the
heart is contracting to push the blood through the
vessels and the diastolic pressure (lower number) is
the pressure when the heart is at rest between con-
tractions. About one in four adult Americans has
hypertension , which is diagnosed when diastolic
blood pressure is consistently at or above 90 mm Hg
or systolic pressure is above 140 mm Hg.
Hypertension typically causes no symptoms
until complications, such as a stroke or heart attack,
occur. It is often detected by routine blood pressure
checks at clinics or doctors’ offices. It is more com-
mon in older people, in African-Americans, in over-
weight individuals, and in people with ...
[10]
Hypertension/PAD/Stroke
[391,5 KB]
From [scientificsessions.americanheart.org] Last viewed: 21.09.2006
Scientific Sessions 2006 • Chicago
Register Online • scientificsessions.org
Session
Hypertension /PAD/Stroke
Start Time
Number
Invited Sessions
Sunday, Nov. 12
Acute Stroke Therapy
9 a.m.
SMP.20
Screening for Peripheral Arterial Disease
9 a.m.
SMP.22
Antithrombotic Therapy for Stroke Prevention in Atrial Fibrillation:Who Should
Be Treated and With What?
5:15 p.m.
CVS.67
Carotid Stent Placement: State of the Art
5:15 p.m.
CVS.33
Diagnostic and Therapeutic Approach to Carotid Artery Disease
5:15 p.m.
CVS.76
Monday, Nov. 13
Management of Modifiable Cardiac Risk Factors in the Renal Disease Patient
7:45 a.m.
HTS.28
Management of Access Site Complications
12:30 p.m.
HTS.14
Stroke Prevention
12:30 p.m.
HTS.13
Collaterals in Acute Ischemic Stroke: Beyond the Clot
5:15 p.m. ...
[11]
Hypertension
[140,8 KB]
From [www.obu.edu] Last viewed: 21.09.2006
of the file http://www.obu.edu/eclinic/documents/Hypertension.doc . G o o g l e automatically generates html versions of documents as we crawl the web. To link to or bookmark this page, use the following url: http://www.google.com/search?q=cache:UMfX_edmKrkJ:www.obu.edu/eclinic/documents/Hypertension.doc+hypertension+filetype:pdf+OR+filetype:doc+OR+filetype:ppt+OR+filetype:xls+OR+filetype:rtf&hl=it&ct=clnk&cd=279&lr=lang_en
Google is neither affiliated with the authors of this page nor responsible for its content.
These search terms have been highlighted:
hypertension
Hypertension
Blood pressure
Blood pressure is the force applied against the walls of the arteries as the heart pumps blood through the body. The pressure is determined by the force and amount of blood pumped and the size and flexibility of the arteries.
Monitoring blood pressure ...
[12]
Hypertension Report #2
[204,6 KB]
From [knoxcounty.org] Last viewed: 21.09.2006
A publication of Surveillance, Evaluation & Research, Knox County Health Department
October 2004
K
nox
C
ounty
H ealth at a G lance
Hypertension Awareness in Knox County
According to the Centers for Disease Control and Prevention, high blood pressure increases the risk for heart
disease and stroke, the first and third most common causes of death in the United States (Ayala et al., 2003;
Arias et al., 2003; see Figure 1). The American Heart Association (2003) estimates that heart disease and
stroke combined accounts for 38.5% of all deaths in the United States, or 1 out of 2.6 deaths.
Figure 1: Percent of 2001 Deaths Due to Heart
Disease and Stroke in the United States:
Total Deaths = 2,416,425
29.0%
6.8%
0%
5%
10%
15%
20%
25%
30%
35%
Heart Disease
Stroke
Percent Mortalities ...
[13]
Hypertension CE Brochure
[94,2 KB]
From [www.state.sd.us] Last viewed: 21.09.2006
Please mark the appropriate fee(s): Option A:
CE program, tailgate networking dinner & football game
$50.00 Pharmacists $45.00
Other Practitioner Participant
$35.00 Guest or Family Member $15.00 S
tudent
$
Name:_ Title:_
Address:_ City:_ State: Zip Code:__
Employer:__Daytime Ph:__ext:_
Email address:__
(Confirmation of registration will be sent to email if given)
Option B:
T
ailgate networking dinner & football game
$
$40.00
Pharmacists
$35.00
Other Practitioner Participant
$25.00
Guest or Family Member
$10.00
S
tudent
Please Read:
T
o
register for this program, enclose this form and a check, money
order or credit charge information for the appropriate amount, made payable to:
South Dakot
a S
t
ate University College of Pharmacy ...
[14]
ANNUAL SCIENTIFIC REPORT 2002 - 2003 -ESC WORKING GROUP ON ...
[15,4 KB]
From [www.escardio.org] Last viewed: 21.09.2006
HYPERTENSION
AWARENESS
Were you ever told that your blood pressure was high?
• In 1997, 23% of Montana adults had been told at some time by a health care professional that their blood
pressure was high.
• There was essentially no difference between sexes with respect to having been told they had high blood pressure.
• The percentage of adults who had ever been told they had high blood pressure increased with increasing age
class. Significantly more adults aged 65 and older were told they had high blood pressure than adults in
younger age classes.
• The percentage of adults reporting high blood pressure has remained approximately the same between 1991
and 1997.
Have you had your blood pressure checked in the past two years?
• Ninety-two percent of Montana adults in 1997 reported having had their blood pressure checked in the last
two years.
• Women were significantly ...
[15]
Hypertension implant has promise
[175,2 KB]
From [www.cvrx.com] Last viewed: 21.09.2006
Last update: July 30, 2006 – 6:12 PM
Hypertension implant has promise
A Maple Grove firm's device to lower stubbornly high blood pressure is attracting
attention -- and deep-pocket investors, as well.
Susan E. Peterson, Star Tribune
Rheos implant
In the lobby of med-tech firm CVRx Inc. hangs a framed snapshot that makes CEO
Robert Kieval smile: a masked surgeon in an operating room holds up a piece of
notebook paper on which he's scrawled, "It works."
The photo was taken during the first operation on a human patient to implant the
company's Rheos system, a device designed to help control high blood pressure in
patients whose condition can't be controlled with medication.
The device, similar in size to a pacemaker, still is undergoing clinical trials and has a long
way to go to win regulatory approval as being safe and effective. Kieval said it will be
several years before it could ...
[16]
Incremental Expenditure of Treating Hypertension in the United States
[106,7 KB]
From [www.abtassociates.com] Last viewed: 21.09.2006
Economics
Incremental Expenditure of
Treating Hypertension in the United States
Sanjeev Balu and Joseph Thomas III
Background: This study determined incremental di-
rect expenditures of treating hypertension in the United
States population.
Methods: Analysis of the 2001 Medical Expenditure
Panel Survey (MEPS), a national probability sample sur-
vey of the civilian noninstitutionalized U.S. population,
was conducted. Hypertensive patients were identified as
those with a medical diagnosis for hypertension based on
International Classification of Diseases (ICD)–9 codes;
patients who were consumers of hypertension -related
medical care services including inpatient and outpatient
visits, emergency room visits, home health visits, office-
based medical provider visits, and other medical expenses;
patients who self-reported being diagnosed with hyperten-
sion by their ...
[17]
Heart and Stroke Foundation of Ontario Social Determinants of ...
[140,0 KB]
From [www.hsf.ca] Last viewed: 21.09.2006
Heart and Stroke Foundation of Ontario
Social Determinants of Hypertension
Special Competition Application
APPLICATION CHECKLIST 2006/2007
COMPLETE AND FORWARD THIS SHEET WITH YOUR APPLICATION
Name of Applicant
Date
A.
CONTENTS OF COMPLETE APPLICATION
The original and EIGHT (8) photocopies of the full application must be assembled and submitted to the Heart and Stroke Foundation of
Ontario (HSFO).
Page ii - Names of suitable referees.
Page 4 - Details of the grant proposal.
Page 1 - All six (6) items must be completed.
Page 5 - Ethics forms and name of administrative officer.
Page 2 - Summary of the proposal.
Page 6 - Budget page, double-checked for mathematical accuracy.
Page 3 - Structured lay summary of the research
proposal completed.
CV -
Complete and attach a copy of Common CV for the principal
investigator and each co-applicant. ...
[18]
High Blood Pressure (Hypertension)
[110,6 KB]
From [www.prodigy.nhs.uk] Last viewed: 21.09.2006
High Blood Pressure ( Hypertension )
What is blood pressure?
Blood pressure is the pressure of blood in your arteries (blood vessels). Blood pressure is
measured in millimetres of mercury (mmHg). Your blood pressure is recorded as two figures. For
example, 150/95 mmHg. This is said as '150 over 95'.
The top (first) number is the systolic pressure. This is the pressure in the arteries when
the heart contracts.
The bottom (second) number is the diastolic pressure. This is the pressure in the
arteries when the heart rests between each heartbeat.
What is high blood pressure?
High blood pressure is a blood pressure that is 140/90 mmHg or above each time it is taken. That
is, the blood pressure is 'sustained' at 140/90 mmHg or above. High blood pressure can be:
just a high systolic pressure, for example, 170/70 mmHg.
just a high ...
[19]
PORTOPULMONARY HYPERTENSION TREATED WITH EPOPROSTENOL: THE UCSF ...
[342,4 KB]
From [www.uwgi.org] Last viewed: 21.09.2006
Topic: Renovascular
Hypertension
Hypertension affects an estimated 10 percent to
25 percent of the U.S. population. Of these, the
great majority have primary elevation of blood
pressure, which can be ameliorated with pharma-
cological treatment. A subset of patients — an
estimated 3 percent to 8 percent — have sec-
ondary hypertension attributable to renovascular
disease caused by narrowing of the renal artery.
1-2
Diminished perfusion to the kidney results in
increased renin secretion and production of
angiotensin II, leading to systemic vasoconstriction
and retention of salt and water. Renovascular hyper-
tension may be present when systemic blood pres-
sure is normal.
Renovascular hypertension has emerged as a
major cause of end-stage renal disease, especially in
the elderly. As the U.S. population ages, the num-
ber of individuals with atherosclerotic ...
[20]
HYPERTENSION
[235,3 KB]
From [www.mrc.ac.za] Last viewed: 21.09.2006
Chronic Diseases of Lifestyle in South Africa since 1995 - 2005
pg 80
CHAPTER 8
HYPERTENSION
IN SOUTH AFRICA
Krisela Steyn
a
High blood pressure (BP) or hypertension is a common condition in South Africa and is a risk factor for heart
attacks, stroke, left ventricular hypertrophy, renal disease, and blindness. People who have hypertension are
usually unaware that they have the condition, unless the BP has been measured at health-care facilities. It is
therefore frequently referred toas a ’silent epidemic’in South Africa. Consequently, hypertension is universally
underdiagnosed and/or inadequately treated resulting in extensive target-organ damage and premature
death. Furthermore, hypertension frequently co-exists with other risk factors for chronic diseases of lifestyle
(CDL), such as diabetes and obesity.
These interrelationships of hypertension with other ...
[21]
Pulmonary Arterial Hypertension
[1440,6 KB]
From [www.caremark.com] Last viewed: 21.09.2006
Background
ulmonary arterial hypertension (PAH) is a disease in
which there is continuous high blood pressure in the
lungs. The disease causes the pulmonary artery and
the small blood vessels in the lungs to constrict or
squeeze, which narrows the openings of these blood
vessels. As a result, blood pressure rises in the arteries of the
lungs. The increased blood pressure in the pulmonary artery
can cause the heart to pump harder to deliver blood throughout
the body. Over time, the heart may become larger than normal
and may lose its ability to pump enough blood to all parts of
the body.
Pulmonary artery = the blood vessel that carries blood
between the heart and lungs
Hypertension = high blood pressure
PAH can be inherited, occur for unknown reasons or be related
to other conditions, such as chronic heart or lung disease or
blood clots in the pulmonary artery. As many as ...
[22]
NP Poster 88 TITLE “What’s all the HYPE about Hypertension ...
[40,1 KB]
From [www.aanp.org] Last viewed: 21.09.2006
NP Poster 88
TITLE
“What’s all the HYPE about Hypertension ?”
AUTHOR INFORMATION
Amy Miller, MSN, CRNP
Kim Miller, CDE, RD
Ellen Bertram, BS
PURPOSE
Increase the community’s knowledge regarding hypertension .
SUMMARY
In response to the escalating number of persons with hypertension in Tioga
County, PA, Laurel Health System, through their quality improvement team, decided on
an approach to increase community awareness of this condition and the devastating
sequelae. The QI team requested and received a grant through the Tioga County
Partnership For Community Health to develop a four part educational series discussing
hypertension . This grant was a Community Access Program Grant funded by the US
Department of Health and Human Services. The program entitled “A Healthy Life with
Hypertension ” is a four-part series. It is designed for 50mins of didactic and 10-20mins
...
[23]
NP Poster 88 TITLE “What’s all the HYPE about Hypertension ...
[40,1 KB]
From [www.aanp.org] Last viewed: 21.09.2006
NP Poster 88
TITLE
“What’s all the HYPE about Hypertension ?”
AUTHOR INFORMATION
Amy Miller, MSN, CRNP
Kim Miller, CDE, RD
Ellen Bertram, BS
PURPOSE
Increase the community’s knowledge regarding hypertension .
SUMMARY
In response to the escalating number of persons with hypertension in Tioga
County, PA, Laurel Health System, through their quality improvement team, decided on
an approach to increase community awareness of this condition and the devastating
sequelae. The QI team requested and received a grant through the Tioga County
Partnership For Community Health to develop a four part educational series discussing
hypertension . This grant was a Community Access Program Grant funded by the US
Department of Health and Human Services. The program entitled “A Healthy Life with
Hypertension ” is a four-part series. It is designed for 50mins of didactic and 10-20mins
...
[24]
Hypertension in England_TrendsCover.psd
[230,7 KB]
From [www.uhce.ox.ac.uk] Last viewed: 21.09.2006
Page 2
Mortality trends in England; ICD9 (401-405), ICD10 (I10-I15); File: Sepho 96-04 V2
Hypertension in England 1996 to 2004.
Mortality trends
Authors: Michael Goldacre, Marie Duncan, Paula Cook-Mozaffari,
Matthew Davidson, Henry McGuiness, Daniel Meddings
Published by: Unit of Health-Care Epidemiology, Oxford University, and
South-East England Public Health Observatory, 2006
This document provides a profile of trends in mortality for hypertension in
England. The period covered is January 1 1996 to December 31 2004. The
data are analysed from mortality files supplied to the South East England
Public Health Observatories (SEPHO) by the Office for National Statistics
(ONS). Mortality rates were calculated for the condition certified as the
underlying cause of death and for the disease certified as any mention on the
death certificates. Age-specific ...
[25]
Hypertension prelims
[1194,5 KB]
From [rcplondon.ac.uk] Last viewed: 21.09.2006
HYPERTENSION
Management of hypertension in adults in primary care:
partial update
This is a partial update of NICE Clinical Guideline 18
(published August 2004). The recommendations in this update
replace the recommendations on pharmacological interventions for
hypertension (section 1.4 of the original NICE guideline, pp103–139 of the
original full guideline). No other recommendations are affected.
The National Collaborating Centre
for Chronic Conditions
Funded to produce guidelines for the NHS by NICE
Published by
British Hypertension Society
Page 2
Hypertension : management of hypertension in adults in primary care
Acknowledgements
We would like to thank the following for their help in producing this guideline:
staff at the University of Newcastle, for providing information from the 2004 NICE
guideline. ...
[26]
ACC.06 ABSTRACT CATEGORIES Myocardial Ischemia and Infarction ...
[20,4 KB]
From [www.acc.org] Last viewed: 21.09.2006
Doc. #323537
8/29/2005
ACC.06 ABSTRACT CATEGORIES
Myocardial Ischemia and Infarction
Myocardial Ischemia/Infarction--Basic
Unstable Ischemic Syndrome--Clinical
Acute Myocardial Infarction--Therapy
Unstable Ischemic Syndrome/Long-Term Outcome
Stable Ischemic Syndrome
Cardiopulmonary Resuscitation/Emergency Cardiac Care/Shock
Coronary Artery Bypass Surgery/Innovative Techniques
Vascular Disease, Hypertension , and Prevention
Vascular Biology/Atherosclerosis/Thrombosis/Endothelium
Vascular--Pathophysiology--Basic/Angiogenesis/Gene Therapy
Vascular--Pathophysiology--Clinical
Peripheral Arterial/Carotid Disease/Aortic Disease
Venous Thrombosis/Pulmonary Embolism/Pulmonary Hypertension
Pharmacology/Hormones/Lipids--Basic
Pharmacology/Hormones/Lipids--Clinical
Hypertension
Risk Assessment and Reduction/Rehabilitation
Valvular Heart ...
[27]
2006 Canadian Hypertension Education Program Guidelines for the ...
[97,8 KB]
From [www.hypertension.ca] Last viewed: 21.09.2006
PRACTICE GUIDELINES
2006 Canadian
Hypertension Education
Program Guidelines
for the management
of hypertension
by pharmacists
Ross T. Tsuyuki, PharmD, MSc, FCSHP, FACC; William Semchuk, MSc, PharmD, FCSHP;
Luc Poirier, BPharm, MSc; Rosemary M. Killeen, RPh, BScPhm;
Finlay A. McAlister, MD, MSc, FRCPC; Norm Campbell, MD, FRCPC;
Denis Drouin, MD; Richard Z. Lewanczuk, MD, PhD, FRCPC;
for the Canadian Hypertension Education Program
CPJ RPC
CANADIAN PHARMACISTS JOURNAL
REVUE DES PHARMACIENS DU CANADA
Knowledge Into Practice
Page 2
C
ontemporary pharmacy practicemandates that
pharmacists take responsibility for medication
management and patient outcomes. Hypertension
is a prevalent and deadly condition; pharmacists,
alone or in collaboration with other health profes-
sionals,should ...
[28]
Hypertension & Homelessness: What Interferes with Treatment
[196,2 KB]
From [www.nhchc.org] Last viewed: 21.09.2006
1
Homeless Health Care Case Report:
Sharing Practice-Based Experience
Volume 2, Number 2 June 2006
Hypertension & Homelessness: What Interferes with Treatment
Sameer Qureshi, RN, MSN, FNP, NPNP; Darlene Tyler, RN, MSN, FNP; Patricia Post, MPA
omeless adults are two-to-four times more likely to have hypertension and other cardiovascular diseases, at
younger ages, than either the general population or low-income adults with stable housing (Szerlip 2002,
Burt 1999, Hwang 1999, Kleinman 1997, White 1997, Kinchen and Wright 1991, Wright 1990, Plantieri et al.
1990, and Gelberg 1990, as cited in Zerger 2002). Among the factors that increase their risk are poor diet and
excessive use of alcohol, nicotine and other drugs that exacerbate elevated blood pressure and damage the heart.
Uncontrolled hypertension (blood pressure >140/90 mm Hg) can lead to heart attack, stroke, or kidney failure. ...
[29]
Review report for SIGN 49: Hypertension in older people
[258,4 KB]
From [www.sign.ac.uk] Last viewed: 21.09.2006
S I G N
PROPOSED REVIEW OF SIGN GUIDELINE 2005
CONSULTATION FORM
Title of guideline
SIGN 49:
Hypertension in older people
Date of publication
2001
SIGN scoping search – sources
MeSH headings for the condition specified, plus any common variations as free text
Sources: Guidelines : NICE; National Library for Health guidelines finder; National
Guidelines Clearinghouse; GIN Web site. Technology appraisals : NICE; UK HTA
database (Southampton); INAHTA database. Cochrane reviews : Cochrane library.
Other good quality systematic review s: UK HTA database (Southampton); DARE.
Individual studies : Embase and Medline. Date of publication - 2005.
SIGN scoping search - summary
Guidelines – 6
HTAs – 0
Cochrane reviews – 3
Other good quality systematic reviews – 8
Individual RCTs – 0 major studies in last 2 years
Other ...
[30]
New GMS Contract QOF Implementation Dataset and Business Rules ...
[86,2 KB]
From [www.primarycarecontracting.nhs.uk] Last viewed: 21.09.2006
Unrestricted
Data and Business Rules – Established Hypertension Indicator Set
Author
Paul Amos
Version No
8.5
Version Date
18-May-2006
New GMS Contract QOF Implementation
Dataset and Business Rules - Established
Hypertension Indicator Set
Page 2
Unrestricted
Hypertension ruleset_R4_v8.5
Version date: 18-May-2006
Amendment History:
Version
Date
Amendment History
0.1
09-Jul-2004
From Peter Horsfield. Extracted from July Read
Code Release. Contains Read v0 only.
1.0
27-Sep-2004
Amended following 4 Country Review
1.1
18-Jan-2005
Amended following January READ Code
Release
1.2
21-Jun-2005
Amended following 4 Country review
2.0
21-July-2005
Signed off following 4 Country review
2.1
21-July-2005
Amended following July 2005 Read Code ...